Miyauchi Masaaki, Toyoda Masao, Kaneyama Noriko, Miyatake Han, Tanaka Eitaro, Kimura Moritsugu, Umezono Tomoya, Fukagawa Masafumi
Division of Nephrology, Endocrinology and Metabolism, Department of Internal Medicine, Tokai University School of Medicine, Kanagawa, Japan.
J Diabetes Res. 2016;2016:5043964. doi: 10.1155/2016/5043964. Epub 2016 Sep 28.
We compared the efficacy of activity monitor (which displays exercise intensity and number of steps) versus that of pedometer in exercise therapy for patients with type 2 diabetes. The study subjects were divided into the activity monitor group ( = 92) and pedometer group ( = 95). The primary goal was improvement in hemoglobin A1c (HbA1c). The exercise target was set at 8,000 steps/day and 20 minutes of moderate-intensity exercise (≥3.5 metabolic equivalents). The activity monitor is equipped with a triple-axis accelerometer sensor capable of measuring medium-intensity walking duration, number of steps, walking distance, calorie consumption, and total calorie consumption. The pedometer counts the number of steps. Blood samples for laboratory tests were obtained during the visits. The first examination was conducted at the start of the study and repeated at 2 and 6 months. A significant difference in the decrease in HbA1c level was observed between the two groups at 2 months. The results suggest that the use of activity level monitor that displays information on exercise intensity, in addition to the number of steps, is useful in exercise therapy as it enhances the concept of exercise therapy and promotes lowering of HbA1c in diabetic patients.
我们比较了活动监测器（可显示运动强度和步数）与计步器在2型糖尿病患者运动治疗中的疗效。研究对象被分为活动监测器组（n = 92）和计步器组（n = 95）。主要目标是改善糖化血红蛋白（HbA1c）。运动目标设定为每天8000步和20分钟中等强度运动（≥3.5代谢当量）。活动监测器配备了一个三轴加速度计传感器，能够测量中等强度步行持续时间、步数、步行距离、卡路里消耗和总卡路里消耗。计步器则计算步数。在就诊期间采集用于实验室检测的血样。首次检查在研究开始时进行，并在2个月和6个月时重复进行。在2个月时，两组之间的HbA1c水平下降存在显著差异。结果表明，使用除步数外还能显示运动强度信息的活动水平监测器，在运动治疗中是有用的，因为它强化了运动治疗的概念，并促进糖尿病患者HbA1c的降低。
